Sarah D. Dahlberg, RAC-Drugs

Managing Scientist
Exponent

Poster(s):

• ((A-265)) (A-265) Assessing Study Feasibility Using Trends in the FDA PMR/PMC Database: 2020-2024
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((A-271)) (A-271) Postmarketing Requirements for Accelerated Approvals: An Analysis of Status, Therapeutic Areas, and Regulatory Designations
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET